Trial Profile
Efficacy and security in the treatment of conjunctivitis by adenovirus treated with opopatadine (Opatanol) and artificial drops (Acuolens) vs pranoprofen (Oftalar) and artificial drops (Acuolens).
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2012
Price :
$35
*
At a glance
- Drugs Olopatadine (Primary) ; Pranoprofen
- Indications Adenovirus infections
- Focus Adverse reactions; Therapeutic Use
- 25 Aug 2011 New trial record